Clinical Trial for Prostate Cancer

Oakwood Laboratories

Status and phase: Completed; Phase 3

Conditions: Prostate Cancer

Treatments: Drug: Leuprolide Acetate for Injectable Suspension 22.5 mg

Study type: Interventional

Funder types: Industry

Identifiers

NCT00076531

OL-007

Details and patient eligibility

About

Phase III trial using an injectable for treatment of prostate cancer.

Sex: Male

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria